Article Versions Notes

Xu X, Ma W, Qiu G, Xuan L, He C, Zhang T, Wang J, Liu Q. Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2. Biology. 2023; 12(10):1337. https://doi.org/10.3390/biology12101337

Xu, Xi, Weiwei Ma, Guo Qiu, Li Xuan, Chong He, Tian Zhang, Jian Wang, and Qifa Liu. 2023. "Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2" Biology 12, no. 10: 1337. https://doi.org/10.3390/biology12101337

Xu, X., Ma, W., Qiu, G., Xuan, L., He, C., Zhang, T., Wang, J., & Liu, Q. (2023). Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2. Biology, 12(10), 1337. https://doi.org/10.3390/biology12101337